Skip to main content

Summary of Various ECG Criteria for Left Ventricular Hypertrophy (LVH)

Summary of Various ECG Criteria for Left Ventricular Hypertrophy (LVH)

Left ventricular hypertrophy (LVH) is an increase in left ventricular myocardial mass, most commonly caused by long-standing hypertension, aortic stenosis, and cardiomyopathies. While echocardiography is the diagnostic gold standard, the electrocardiogram (ECG) remains a widely used screening and prognostic tool. Multiple ECG criteria have been developed to improve detection of LVH, each with its own strengths and limitations.

---

Voltage-Based Criteria


Sokolow–Lyon Criteria

This is the most traditional and commonly taught criterion. LVH is suggested when the sum of the S wave in V1 and the R wave in V5 or V6 is ≥35 mm, or when the R wave in V5 or V6 alone is ≥26 mm. Although easy to remember, its sensitivity is low, particularly in obese individuals and older adults.


Cornell Voltage Criteria

LVH is present when the sum of the S wave in V3 and the R wave in aVL exceeds 28 mm in men or 20 mm in women. Compared with Sokolow–Lyon, this criterion has better specificity and performs particularly well in women.


Peguero–Lo Presti Criteria

This newer voltage criterion uses the deepest S wave in any lead plus the S wave in V4. A total ≥28 mm in men or ≥23 mm in women suggests LVH. Studies show improved sensitivity compared with older voltage-based methods.



---


Voltage Plus Duration Criteria


Cornell Voltage-Duration Product

This criterion multiplies the Cornell voltage (SV3 + RaVL) by the QRS duration. A value ≥2440 mm·ms indicates LVH. Including QRS duration improves diagnostic accuracy and correlates better with left ventricular mass.



---


Point-Based Criteria


Romhilt–Estes Point Score System

This system assigns points to multiple ECG features including increased QRS voltage, ST-T strain pattern, left atrial enlargement, left axis deviation, prolonged QRS duration, and delayed intrinsicoid deflection. A score ≥5 points indicates definite LVH, while 4 points suggests probable LVH. It offers higher specificity but is more complex to apply.



---


Repolarization-Based Features


LVH Strain Pattern

LVH may be associated with downsloping ST-segment depression and asymmetric T-wave inversion in lateral leads (I, aVL, V5–V6). Although not diagnostic alone, the strain pattern indicates advanced hypertrophy and is associated with increased cardiovascular risk.



---


Limitations of ECG Criteria


Low sensitivity: many patients with echo-proven LVH have normal ECGs


ECG voltages are influenced by body habitus, age, lung disease, and chest wall thickness


No single criterion is universally superior




---


Clinical Significance


Despite limitations, ECG-detected LVH is a strong independent predictor of cardiovascular morbidity and mortality. Regression of LVH on ECG with antihypertensive therapy is associated with improved clinical outcomes.



---


Key Message


ECG criteria for LVH provide valuable screening and prognostic information. Using multiple criteria together and interpreting them in the clinical context improves diagnostic yield, with echocardiography remaining essential for confirmation.



 

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...